lactic acid and physostigmine

lactic acid has been researched along with physostigmine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's2 (28.57)29.6817
2010's1 (14.29)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Babu, SR; Buckenmeyer, P; Knowlton, RG; Somani, SM1
Babu, SR; Buckenmeyer, PJ; Knowlton, RG; Somani, SM1
Hussain, MA; Mollica, JA1
Chaw, CS; Moochhala, S; Tan, CW; Wang, L; Yang, YY1
Chaw, CS; Heller, J; Moochhala, SM; Ng, S; Wang, L; Yang, YY; Zhao, B1
Campos, HO; Coimbra, CC; Drummond, LR; Marubayashi, U; Rodrigues, AG1

Other Studies

7 other study(ies) available for lactic acid and physostigmine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Effect of physostigmine on plasma lactate and pyruvate in untrained/trained rats.
    Pharmacology, biochemistry, and behavior, 1992, Volume: 42, Issue:1

    Topics: Animals; Lactates; Lactic Acid; Male; Physical Conditioning, Animal; Physical Exertion; Physostigmine; Pyruvates; Pyruvic Acid; Rats; Rats, Inbred Strains

1992
Effect of concurrent exercise and physostigmine on lactate and pyruvate in plasma, muscle, and brain tissue of rats.
    Pharmacology, biochemistry, and behavior, 1994, Volume: 47, Issue:4

    Topics: Animals; Brain; Kinetics; Lactates; Lactic Acid; Male; Muscles; Physical Exertion; Physostigmine; Pyruvates; Pyruvic Acid; Rats; Rats, Sprague-Dawley; Tissue Distribution

1994
Polylactide-polyglycolide delivery system for physostigmine.
    Journal of pharmaceutical sciences, 1993, Volume: 82, Issue:5

    Topics: Animals; Biocompatible Materials; Drug Implants; Lactic Acid; Male; Physostigmine; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Inbred Lew

1993
Design of physostigmine-loaded polymeric microparticles for pretreatment against exposure to organophosphate agents.
    Biomaterials, 2003, Volume: 24, Issue:7

    Topics: Biopolymers; Chemistry, Pharmaceutical; Cholinesterase Inhibitors; Insecticides; Lactic Acid; Microspheres; Organophosphorus Compounds; Particle Size; Physostigmine; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solubility

2003
Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying.
    Biomaterials, 2004, Volume: 25, Issue:16

    Topics: Body Fluids; Coated Materials, Biocompatible; Diffusion; Drug Carriers; Drug Implants; Drug Stability; Kinetics; Lactic Acid; Manufactured Materials; Materials Testing; Microspheres; Particle Size; Physostigmine; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Surface Properties

2004
Effects of Increased Central Cholinergic Activity on the Metabolic Challenge Induced by Submaximal Exercise in Rats: Adrenomedullary Secretion Influences.
    Pharmacology, 2022, Volume: 107, Issue:1-2

    Topics: Adrenal Medulla; Animals; Blood Glucose; Cholinergic Fibers; Cholinesterase Inhibitors; Fatty Acids, Nonesterified; Injections, Intraventricular; Lactic Acid; Male; Metabolism; Physical Conditioning, Animal; Physical Exertion; Physostigmine; Rats, Wistar

2022